Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Dutcher

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
Current Opinion in Oncology|November 1, 1995
Therapeutic strategies for cytokinesJ P Dutcher
Seminars in Nuclear Medicine|July 1, 1984
Labeled cells in patients with malignancyJ P Dutcher
The American Journal of the Medical Sciences|March 1, 1984
Granulocyte transfusion therapyJ P Dutcher
Current Opinion in Oncology|February 1, 1990
Therapy for acute leukemia in adultsJ P Dutcher
Cancer Investigation|January 1, 1989
The potential benefit of granulocyte transfusion therapyJ P Dutcher
Journal of Clinical Apheresis|January 1, 1990
Lymphokine-activated killer cells/tumor-infiltrating lymphocytes therapy: efficacy, toxicity, controversiesJ P Dutcher
Advances in Immunity and Cancer Therapy|January 1, 1986
Platelet and granulocyte transfusions in cancer patientsJ P Dutcher
Hematology/Oncology Clinics of North America|June 1, 1987
Hematologic abnormalities in patients with nonhematologic malignanciesJ P Dutcher
Cancer Investigation|January 1, 1987
Controversies in oncologyJ P Dutcher
Current Opinion in Urology|September 27, 2000
Immunotherapy: are we making a difference?J P Dutcher
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
Current Opinion in Oncology|November 1, 1995
Therapeutic strategies for cytokinesJ P Dutcher
Seminars in Nuclear Medicine|July 1, 1984
Labeled cells in patients with malignancyJ P Dutcher
The American Journal of the Medical Sciences|March 1, 1984
Granulocyte transfusion therapyJ P Dutcher
Current Opinion in Oncology|February 1, 1990
Therapy for acute leukemia in adultsJ P Dutcher
Cancer Investigation|January 1, 1989
The potential benefit of granulocyte transfusion therapyJ P Dutcher
Journal of Clinical Apheresis|January 1, 1990
Lymphokine-activated killer cells/tumor-infiltrating lymphocytes therapy: efficacy, toxicity, controversiesJ P Dutcher
Advances in Immunity and Cancer Therapy|January 1, 1986
Platelet and granulocyte transfusions in cancer patientsJ P Dutcher
Hematology/Oncology Clinics of North America|June 1, 1987
Hematologic abnormalities in patients with nonhematologic malignanciesJ P Dutcher
Cancer Investigation|January 1, 1987
Controversies in oncologyJ P Dutcher
Current Opinion in Urology|September 27, 2000
Immunotherapy: are we making a difference?J P Dutcher
Pageof 16